Terms: = Breast cancer AND CD52, CDW52, EDDM5 AND Staging
1 results:
1. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive breast Carcinoma That Modulates the Tumor Microenvironment.
Chen Y; Meng Z; Zhang L; Liu F
Front Immunol; 2021; 12():664845. PubMed ID: 33968066
[TBL] [Abstract] [Full Text] [Related]
